The relationship between exercise capacity and different functional markers in pulmonary rehabilitation for COPD

Maria Kerti, Zsuzsanna Balogh, Krisztina Kelemen, Janos T Varga, Maria Kerti, Zsuzsanna Balogh, Krisztina Kelemen, Janos T Varga

Abstract

Rationale: The relationship of functional parameters such as lung mechanics, chest kinematics, metabolism and peripheral and respiratory muscle function with the level of exercise tolerance remains a controversial subject. While it has been previously shown that pulmonary rehabilitation is capable of improving exercise tolerance in patients afflicted by COPD, as expressed by values of 6-minute walking test (6MWT), the degree of contribution to this change by each of the aforementioned parameters remains unclear.

Aims: To investigate the correlation between changes in exercise capacity and other functional markers following pulmonary rehabilitation in COPD and to determine which parameters are more closely related to improvements of exercise tolerance.

Materials and methods: Three hundred and twenty-seven patients with COPD (with average, 95% CI for forced expiratory volume in the first second [FEV1]: 45% [25%-83%] predicted, age: 64 [48-80] years, and BMI: 27 [13.5-40.4] kg/m2) participated in this study. Thirty percent of the patients had pulmonary hypertension as comorbidity. Patients underwent a pulmonary rehabilitation program with 20-30 minutes sessions two to three times per day for 4 weeks. The program was composed of chest wall-stretching, controlled breathing exercises, and a personalized training schedule for cycling and treadmill use. Measurements of 6MWT, lung function, chest wall expansion, grip strength, maximal inspiratory pressure, and breath holding time were taken. The Body mass index, airflow Obstruction, Dyspnea and Exercise capacity (BODE-index), body mass index [BMI], FEV1, 6MWT, modified Medical Research Dyspnea Scale score, and an alternative scale score (for BMI, FEV1, 6MWT, and COPD Assessment Test) were calculated.

Results: Rehabilitation resulted in a generalized improvement in 6MWT among patients (average: 360 [95% CI: 178-543 m] vs average: 420 [95% CI: 238-601 m], p<0.05). Improvements in exercise tolerance were found to be most closely associated with changes in composite BODE-index (R2=-0.6), Alternative Scale (R2=-0.56), dyspnea score (modified Medical Research Dyspnea Scale R2=-0.54), and health status (COPD Assessment Test R2=-0.4, p<0.05). In addition, improvements in exercise tolerance were found to moderately correlate with improvements in inspiratory vital capacity (IVC, R2=0.34, p<0.05). Post-rehabilitation changes in IVC displayed a connection with grip strength (R2=0.6) and chest expansion (R2=0.48).

Conclusion: Enhancements in exercise tolerance had correlation with changes in IVC, BODE-index, and the new Alternative Scale. However, comprehensive assessment needs to include considerations of chest kinematics and peripheral and respiratory muscle function as well.

Keywords: breath holding time; exercise tolerance; health status; lung mechanics; respiratory and peripheral muscle function.

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Scatterplot of 6-minutes walking test (6MWD in m) between values at the start of rehabilitation and the change as an effect of rehabilitation. Abbreviation: 6MWD, 6-minute walking distance.
Figure 2
Figure 2
Scatterplot of inspiratory vital capacity (IVC) between the values at the start of rehabilitation and the change as an effect of rehabilitation.

References

    1. Chaitow L, Breadly D, Gilbert C, Ley R. Multidisciplinary Approaches to Breathing Pattern Disorders. Amsterdam: Elsevier B.V.; 2013. The structure and function of breathing; pp. 1–41.
    1. Ambrosino N, Simonds A. The clinical management in extremely severe COPD. Respir Med. 2007;101(8):1613–1624.
    1. Jones PW, Tabberer M, Chen WH. Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT™) scores. BMC Pulm Med. 2011;11:42.
    1. Launois C, Barbe C, Bertin E, et al. The modified Medical Research Council scale for the assessment of dyspnea in daily living in obesity: a pilot study. BMC Pulm Med. 2012;12:61.
    1. Funk GC, Kirchheiner K, Burghuber OC, Hartl S. BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD – a cross-sectional study. Respir Res. 2009;10:1.
    1. Rochester CL, Vogiatzis I, Holland AE, et al. ATS/ERS Task Force on Policy in Pulmonary Rehabilitation An official American Thoracic Society/European Respiratory Society Policy Statement: enhancing implementation, use, and delivery of pulmonary rehabilitation. Am J Respir Crit Care Med. 2015;192(11):1373–1386.
    1. Varga J, Porszasz J, Boda K, Casaburi R, Somfay A. Supervised high intensity continuous and interval training vs. self-paced training in COPD. Respir Med. 2007;101(11):2297–2304.
    1. de Sá RB, Pessoa MF, Cavalcanti AGL, Campos SL, Amorim C, Dornelas de Andrade A. Immediate effects of respiratory muscle stretching on chest wall kinematics and electromyography in COPD patients. Respir Physiol Neurobiol. 2017;242:1–7.
    1. Jones PW, Agusti AG. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J. 2006;27(4):822–832.
    1. Cote CG, Celli BR. Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J. 2005;26(4):630–636.
    1. Kerti M, Balogh ZS, Halasz A, Kelemen K, Varga J. COPD Assessment for Symptoms and Functional Condition in Pulmonary Rehabilitation. Amsterdam: ERS Annual Congress; 2015. p. 2218.
    1. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European Respiratory Society. Eur Respir J. 1993;16:5–40.
    1. Balke B. A simple field test for the assessment of physical fitness Rep 63-6. Rep Civ Aeromed Res Inst US. 1963:1–8.
    1. Holland AE, Spruit MA, Troosters T, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428–1446.
    1. Debouche S, Pitance L, Robert A, Liistro G, Reychler G. Reliability and reproducibility of chest wall expansion measurement in young healthy adults. J Manipulative Physiol Ther. 2016;39(6):443–449.
    1. Neumeister W, Rasche K, Maas P, Monnerjahn C, Singh B, Schultze-Werninghaus G. Reproduzierbarkeit der EDV-gestützte Mund Okklusion Druckmessungen [Reproducibility of computer-assisted mouth occlusion pressure measurements] Med Klin (Munich) 1996;91(Suppl 2):73–75. German.
    1. Mirsky IA, Lipman E, Grinker RR. Breath holding time in anxiety states. Fed Proc. 1946;5(1 Pt 2):74.
    1. Shingai K, Kanezaki M. Effect of dyspnea induced by breath-holding on maximal muscular strength of patients with COPD. J Phys Ther Sci. 2014;26(2):255–258.
    1. An KN, Chao NY, Askew LJ. Hand strength measurement instruments. Arch Phys Med Rehabil. 1980;61(8):366–368.
    1. Jeong M, Kang HK, Song P, et al. Hand grip strength in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2017;12:2385–2390.
    1. Aliverti A, Cala SJ, Duranti R, et al. Human respiratory muscle actions and control during exercise. J Appl Physiol (1985) 1997;83(4):1256–1269.
    1. Kenyon CM, Cala SJ, Yan S, et al. Rib cage mechanics during quiet breathing and exercise in humans. J Appl Physiol (1985) 1997;83(4):1242–1255.
    1. Aliverti A, Ghidoli G, Dellacà RL, Pedotti A, Macklem PT. Chest wall kinematic determinants of diaphragm length by optoelectronicplethysmography and ultrasonography. J Appl Physiol (1985) 2003;94(2):621–630.
    1. Romagnoli I, Gigliotti F, Galarducci A, et al. Chest wall kinematics and respiratory muscle action in ankylosing spondylitis patients. Eur Respir J. 2004;24(3):453–460.
    1. Alter A, Aboussouan LS, Mireles-Cabodevila E. Neuromuscular weakness in chronicobstructive pulmonary disease: chest wall, diaphragm, and peripheral muscle contributions. Curr Opin Pulm Med. 2017;23(2):129–138.
    1. O’Donnel DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164(5):770–777.
    1. O’Donnell DE, Webb KA. Breathlessness in patients with severe chronic airflow limitation; physiological correlates. Chest. 1992;102(3):824–831.
    1. Petrovic M, Reiter M, Zipko H, Pohl W, Wanke T. Effects of inspiratory muscle training on dynamic hyperinflation in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:797–805.
    1. Beckerman M, Magadle R, Weiner M, Weiner P. The effects of 1 year of specific inspiratory muscle training in patients with COPD. Chest. 2005;128(5):3177–3182.
    1. Albuquerque AL, Quaranta M, Chakrabarti B, Aliverti A, Calverley PM. Exercise performance and differences in physiological response to pulmonary rehabilitation in severe chronic obstructive pulmonary disease with hyperinflation. J Bras Pneumol. 2016;42(2):121–129.
    1. O’Donnell DE, Laveneziana P. The clinical importance of dynamic lung hyperinflation in COPD. COPD. 2006;3(4):219–232.
    1. Aslan GK, Akinci B, Yeldan I, Okumus G. Respiratory muscle strength in patients with pulmonary hypertension: the relationship with exercise capacity, physical activity level, and quality of life. Clin Respir J. 2016 Nov 17; Epub.
    1. Varga J. Mechanisms to dyspnoea and dynamic hyperinflation related exercise intolerance in COPD. Act Physiol Hung. 2015;102(2):163–175.
    1. Casaburi R, Patessio A, Ioli F, Zanaboni S, Donner CF, Wasserman K. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis. 1991;143(1):9–18.
    1. Rocha T, Souza H, Brandão DC, et al. The manual diaphragm release technique improves diaphragmatic mobility, inspiratory capacity and exercise capacity in people with chronic obstructive pulmonary disease: a randomised trial. J Physiother. 2015;61(4):182–189.
    1. Vagvolgyi A, Rozgonyi Z, Kerti M, Vadasz P, Varga J. Effectiveness of perioperative pulmonary rehabilitation in thoracic surgery. J Thorac Dis. 2017;9(6):1584–1591.
    1. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med. 1996;153(3):976–980.
    1. Sandoz JS, Roberts MM, Cho JG, Wheatley JR. Magnitude of exercise capacity and quality of life improvement following repeat pulmonary rehabilitation in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:1085–1091.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅